ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ZYDUSLIFE NEWS why is Zydus Lifesciences Ltd price falling or rising

ZYDUSLIFE NEWS reasons for why stock price of Zydus Lifesciences Ltd is falling or rising

ZYDUSLIFE Zydus Lifesciences is falling or rising technical reasons

Technical analysis forecast for Zydus Lifesciences Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Zydus Lifesciences ZYDUSLIFE at this time. Stock is falling and might fall more.

It appears as if Zydus Lifesciences ZYDUSLIFE gave a large move recently.

Stock of Zydus Lifesciences (ZYDUSLIFE) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.

Although my analysis for Zydus Lifesciences is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 902.5, for a target of 913.7 or 922.99

ZYDUSLIFE Zydus Lifesciences is falling or rising NEWS fundamental reasons

Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2025-12-29

Company Announcement Zydus Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2025-12-26

Company Announcement - NEWS as on 2025-12-26

Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®. NUFYMCO®. BLA has been app - NEWS as on 2025-12-24

Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 19, 2025, titled "Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India". - NEWS as on 2025-12-19

Company Announcement Zydus Lifesciences Limited has informed the Exchange about General Updates - NEWS as on 2025-12-17

Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 15, 2025, titled "Sentynl Therapeutics Announces FDA Acceptance of CUTX-101 NDA Resubmission". - NEWS as on 2025-12-16

Company Announcement Zydus Lifesciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results along with copy of minutes. - NEWS as on 2025-12-15

Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 10, 2025, titled "Zydus launches biosimilar Denosumab 120 mg SC protecting bone health in cancer patients". - NEWS as on 2025-12-10

Zydus Lifesciences introduces biosimilar to protect bone health in cancer patients Zydus Lifesciences has launched Zyrifa, a Denosumab biosimilar, for treating osteoporosis and preventing skeletal complications in cancer patients. Priced at Rs 12,495, the drug aims to improve access and affordability for patients with bone metastases fro - NEWS as on 2025-12-10 indiatimes.com

Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 04, 2025, titled "Zydus receives EIR for the injectable facility located at Jarod". - NEWS as on 2025-12-04

More announcements and NEWS

ZYDUSLIFE Zydus Lifesciences Ltd current price & indicator signals

Moving Averages for Zydus Lifesciences Ltd

  • 5Day Average: 915.99
  • 12Day Average: 918.25
  • 20Day Average: 923.44
  • 50Day Average: 946.35
  • 100Day Average: 972
  • 150Day Average: 970.29
  • 200Day Average: 949.05

ZYDUSLIFE Indicators & signals

Indicator MACD (12,26,9)

918.09, 926.95, -9.03
Indicator MACD is in negative zone

Indicator ADX (14)

12.84, 15.81, 20.47
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ZYDUSLIFE Zydus Lifesciences Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Mon Dec 2025 904.60 902.25 to 914.60 -0.76% 0.95 times
26 Fri Dec 2025 911.55 909.00 to 920.00 -0.68% 0.6 times
24 Wed Dec 2025 917.80 916.00 to 937.00 -1.08% 1.46 times
23 Tue Dec 2025 927.80 915.45 to 932.25 1.05% 0.63 times
22 Mon Dec 2025 918.20 917.30 to 928.00 -0.15% 0.94 times
19 Fri Dec 2025 919.60 911.25 to 929.60 0.65% 1.56 times
18 Thu Dec 2025 913.65 909.35 to 918.25 -0.48% 0.69 times
17 Wed Dec 2025 918.10 914.10 to 920.45 0.41% 1.04 times
16 Tue Dec 2025 914.35 912.00 to 928.95 -0.79% 1.47 times
15 Mon Dec 2025 921.60 916.10 to 929.00 -0.81% 0.78 times
12 Fri Dec 2025 929.15 923.05 to 932.00 0.72% 0.85 times
11 Thu Dec 2025 922.55 919.80 to 927.20 -0.11% 1.02 times

Videos related to: ZYDUSLIFE NEWS why is Zydus Lifesciences Ltd price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

ZYDUSLIFE NEWS why is Zydus Lifesciences Ltd price falling or rising

 

Back to top